Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|ABBV-221||Losatuxizumab vedotin||EGFR Antibody 29||ABBV-221 (Losatuxizumab vedotin) is an antibody-drug conjugate that consists of a monoclonal EGFR antibody and a cytotoxic molecule, MMAE, which demonstrates anti-tumor activity against EGFR-expressing tumors (PMID: 29483208).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT02365662||Phase I||ABBV-221||A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor||Terminated|